101
Participants
Start Date
June 6, 2019
Primary Completion Date
December 20, 2019
Study Completion Date
March 20, 2020
t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
Eligible participants will be use the t:slim X2 with Control-IQ Technology \& Dexcom G6 CGM technology for 16 weeks during the main study. All participants will be provided the option of continue using the t:slim X2 with Control-IQ system in a 12 week Extension Phase. This arm to be uset:slim X2 with Control-IQ Technology \& Dexcom G6 CGM
Control Group
Eligible participants will be use the study Dexcom G6 CGM for 16 weeks during the main study. All participants will be provided the option of using the t:slim X2 with Control-IQ system in a 12 week Extension Phase.
UVA Center for Diabetes Technology, Charlottesville
Barbara Davis Center, University of Colorado, Aurora
Stanford University, Stanford
Yale University, New Haven
Collaborators (1)
Tandem Diabetes Care, Inc.
INDUSTRY
DexCom, Inc.
INDUSTRY
Jaeb Center for Health Research
OTHER
University of Virginia
OTHER